{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:00:54Z","timestamp":1791021654255,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004881","name":"Instituto Mexicano del Seguro Social","doi-asserted-by":"publisher","award":["FIS\/IMSS\/PROT\/G15\/1453"],"award-info":[{"award-number":["FIS\/IMSS\/PROT\/G15\/1453"]}],"id":[{"id":"10.13039\/501100004881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10620-019-05830-0","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T11:03:01Z","timestamp":1569236581000},"page":"1134-1143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5457-1990","authenticated-orcid":false,"given":"Grettel","family":"Garc\u00eda-Collinot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7254-6350","authenticated-orcid":false,"given":"Eduardo Osiris","family":"Madrigal-Santill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6921-204X","authenticated-orcid":false,"given":"Michel A.","family":"Mart\u00ednez-Bencomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9686-4046","authenticated-orcid":false,"given":"Rosa A.","family":"Carranza-Muleiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-593X","authenticated-orcid":false,"given":"Luis J","family":"Jara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8729-9775","authenticated-orcid":false,"given":"Olga","family":"Vera-Lastra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8558-3943","authenticated-orcid":false,"given":"Daniel H.","family":"Montes-Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5891-8653","authenticated-orcid":false,"given":"Gabriela","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7118-9395","authenticated-orcid":false,"given":"Mar\u00eda Pilar","family":"Cruz-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,23]]},"reference":[{"key":"5830_CR1","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"23","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Simms R, Distler O, et al. Systemic sclerosis. Nat Rev Dis Primers. 2015;23:15002. \nhttps:\/\/doi.org\/10.1038\/nrdp.2015.2\n\n.","journal-title":"Nat Rev Dis Primers"},{"key":"5830_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11926-011-0217-3","volume":"14","author":"G Gyger","year":"2012","unstructured":"Gyger G, Baron M. Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management. Curr Rheumatol Rep. 2012;14:22\u201329. \nhttps:\/\/doi.org\/10.1007\/s11926-011-0217-3\n\n.","journal-title":"Curr Rheumatol Rep"},{"key":"5830_CR3","doi-asserted-by":"publisher","first-page":"7062","DOI":"10.3748\/wjg.v19.i41.7062","volume":"19","author":"XP Tian","year":"2013","unstructured":"Tian XP, Zhang X. Gastrointestinal complications of systemic sclerosis. World J Gastroenterol. 2013;19:7062\u20137068. \nhttps:\/\/doi.org\/10.3748\/wjg.v19.i41.7062","journal-title":"World J Gastroenterol"},{"key":"5830_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/2040622313496126","volume":"4","author":"AH Sachdev","year":"2013","unstructured":"Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis. 2013;4:223\u2013231. \nhttps:\/\/doi.org\/10.1177\/2040622313496126\n\n.","journal-title":"Ther Adv Chronic Dis"},{"key":"5830_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/rheumatology\/34.3.265","volume":"34","author":"SA Kaye","year":"1995","unstructured":"Kaye SA, Lim SG, Taylor M, Patel S, Gillespie Black CM. Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol. 1995;34:265\u2013269.","journal-title":"Br J Rheumatol"},{"key":"5830_CR6","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/rheumatology\/kep226","volume":"48","author":"I Marie","year":"2009","unstructured":"Marie I, Ducrott\u00e9 P, Denis P, Menard JF, Levesque H. Small intestinal bacterial overgrowth in systemic sclerosis. Rheumatology (Oxford). 2009;48:1314\u20131319. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/kep226\n\n.","journal-title":"Rheumatology (Oxford)."},{"key":"5830_CR7","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11%3C2437::AID-ANR10%3E3.0.CO;2-U","volume":"43","author":"V Steen","year":"2000","unstructured":"Steen V, Medsger T. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43:2437\u20132444. \nhttps:\/\/doi.org\/10.1002\/1529-0131(200011)43:11%3C2437:AID-ANR10%3E3.0.CO;2-U\n\n.","journal-title":"Arthritis Rheum"},{"key":"5830_CR8","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s00296-017-3753-y","volume":"37","author":"MP Cruz-Dom\u00ednguez","year":"2017","unstructured":"Cruz-Dom\u00ednguez MP, Garc\u00eda-Collinot G, Saavedra MA, et al. Malnutrition is an independent risk factor for mortality in Mexican patients with systemic sclerosis: a cohort study. Rheumatol Int. 2017;37:1101\u20131109. \nhttps:\/\/doi.org\/10.1007\/s00296-017-3753-y\n\n.","journal-title":"Rheumatol Int"},{"key":"5830_CR9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/apt.12479","volume":"38","author":"SC Shah","year":"2013","unstructured":"Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2013;38:925\u2013934. \nhttps:\/\/doi.org\/10.1111\/apt.12479\n\n.","journal-title":"Aliment Pharmacol Ther"},{"key":"5830_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2174\/15748847113089990048","volume":"8","author":"R Rosania","year":"2013","unstructured":"Rosania R, Giorgio F, Principi M, et al. Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation. Curr Clin Pharmacol. 2013;8:169\u2013172. \nhttps:\/\/doi.org\/10.2174\/15748847113089990048\n\n.","journal-title":"Curr Clin Pharmacol"},{"key":"5830_CR11","doi-asserted-by":"publisher","first-page":"14874","DOI":"10.1038\/s41598-017-14889-6","volume":"7","author":"V Patrone","year":"2017","unstructured":"Patrone V, Puglisi E, Cardinali M, et al. Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement. Sci Rep. 2017;7:14874.","journal-title":"Sci Rep"},{"key":"5830_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.medmal.2017.07.001","volume":"47","author":"C Neut","year":"2017","unstructured":"Neut C, Mahieux S, Dubreuil LJ. Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics? Med Mal Infect. 2017;47:477\u2013483.","journal-title":"Med Mal Infect"},{"key":"5830_CR13","doi-asserted-by":"publisher","first-page":"117955221775267","DOI":"10.1177\/1179552217752679","volume":"11","author":"MI Mor\u00e9","year":"2018","unstructured":"Mor\u00e9 MI, Vandenplas Y. Saccharomyces boulardii CNCM I-745 improves intestinal enzyme function: a trophic effects review. Clin Med Insights Gastroenterol. 2018;11:1179552217752679.","journal-title":"Clin Med Insights Gastroenterol"},{"key":"5830_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1439-0507.2008.01545.x","volume":"52","author":"I Fidan","year":"2009","unstructured":"Fidan I, Kalkanci A, Yesilyurt E, et al. Effects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicans. Mycoses. 2009;52:29\u201334.","journal-title":"Mycoses"},{"key":"5830_CR15","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/rheumatology\/key175","volume":"57","author":"N Pittman","year":"2018","unstructured":"Pittman N, Rawn SM, Wang M, Masetto A, Beattie KA, Larch\u00e9 M. Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review. Rheumatology (Oxford). 2018;57:1802\u20131811.","journal-title":"Rheumatology (Oxford)"},{"key":"5830_CR16","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Van den Hoogen","year":"2013","unstructured":"Van den Hoogen F, Khanna D, Fransen J, et al. Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747\u20131755. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2013-204424\n\n.","journal-title":"Ann Rheum Dis"},{"key":"5830_CR17","first-page":"1573","volume":"28","author":"E LeRoy","year":"2001","unstructured":"LeRoy E, Medsger T. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28:1573\u20131576.","journal-title":"J Rheumatol"},{"key":"5830_CR18","first-page":"431","volume":"15","author":"GC Maya","year":"2009","unstructured":"Maya GC. Pruebas de aliento basadas en hidr\u00f3geno. Med Lab. 2009;15:431\u2013455.","journal-title":"Med Lab"},{"key":"5830_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5056\/jnm.2010.16.3.299","volume":"16","author":"S Kumar","year":"2010","unstructured":"Kumar S, Misra A, Ghoshal UC. Patients with irritable bowel syndrome exhale more hydrogen than healthy subjects in fasting state. J Neurogastroenterol Motil. 2010;16:299\u2013305. \nhttps:\/\/doi.org\/10.5056\/jnm.2010.16.3.299\n\n.","journal-title":"J Neurogastroenterol Motil"},{"key":"5830_CR20","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1046\/j.1365-2036.2003.01800.x","volume":"18","author":"F Castiglione","year":"2003","unstructured":"Castiglione F, Rispo A, Di Girolamo E, et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn\u2019s disease. Aliment Pharmacol Ther. 2003;18:1107\u20131112. \nhttps:\/\/doi.org\/10.1046\/j.1365-2036.2003.01800.x\n\n.","journal-title":"Aliment Pharmacol Ther"},{"key":"5830_CR21","first-page":"188","volume":"132","author":"W Hochter","year":"1990","unstructured":"Hochter W, Chase D, Hagenhoff G. Saccharomyces boulardii in acute adult diarrhea: efficacy and tolerability of treatment. Munch Med Wschr. 1990;132:188\u2013192.","journal-title":"Munch Med Wschr"},{"key":"5830_CR22","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.3748\/wjg.v9.i8.1832","volume":"9","author":"F Mansour-Ghanaei","year":"2003","unstructured":"Mansour-Ghanaei F, Dehbashi N, Yazdanparast K, Shafaghi A. Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis. World J Gastroenterol. 2003;9:1832\u20131833. \nhttps:\/\/doi.org\/10.3748\/wjg.v9.i8.1832\n\n.","journal-title":"World J Gastroenterol"},{"key":"5830_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.phrs.2015.04.005","volume":"97","author":"J Garrido-Mesa","year":"2015","unstructured":"Garrido-Mesa J, Algieri F, Rodriguez-Nogales A, et al. A new therapeutic association to manage relapsing experimental colitis: doxycycline plus Saccharomyces boulardii. Pharmacol Res.. 2015;97:48\u201363. \nhttps:\/\/doi.org\/10.1016\/j.phrs.2015.04.005\n\n.","journal-title":"Pharmacol Res."},{"key":"5830_CR24","first-page":"323","volume":"40","author":"LO Soifer","year":"2010","unstructured":"Soifer LO, Peralta D, Dima G, Besasso H. Eficacia comparativa de un probi\u00f3tico vs un antibi\u00f3tico en la respuesta cl\u00ednica de pacientes con sobrecrecimiento bacteriano del intestino y distensi\u00f3n abdominal cr\u00f3nica funcional: un estudio piloto. Acta Gastroenterol Latinoam. 2010;40:323\u2013327.","journal-title":"Acta Gastroenterol Latinoam"},{"key":"5830_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/00365521.1997.11720717","volume":"222","author":"S Salminen","year":"1997","unstructured":"Salminen S, Salminen E. Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J Gastroenterol Suppl. 1997;222:45\u201348. \nhttps:\/\/doi.org\/10.1080\/00365521.1997.11720717\n\n.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"5830_CR26","unstructured":"Medicamentos PLM \nhttp:\/\/www.medicamentosplm.com\/home\/productos\/lactulax_jarabe\/168\/63\/8311\/94\n\n. Accessed 2 May 2018."},{"key":"5830_CR27","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1136\/gut.26.12.1349","volume":"26","author":"DG Thompson","year":"1985","unstructured":"Thompson DG, Binfield P, De Belder A, O\u2019Brien J, Warren S, Wilson M. Extra intestinal influences on exhaled breath hydrogen measurements during the investigation of gastrointestinal disease. Gut. 1985;26:1349\u20131352.","journal-title":"Gut"},{"key":"5830_CR28","first-page":"436","volume":"105","author":"JA Perman","year":"1985","unstructured":"Perman JA, Modler S, Engel RR, Heldt G. Effect of ventilation on breath hydrogen measurements. J Lab Clin Med. 1985;105:436\u2013439.","journal-title":"J Lab Clin Med"},{"key":"5830_CR29","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/gut.19.7.602","volume":"19","author":"T Gilat","year":"1978","unstructured":"Gilat T, Ben Hur H, Gelman-Malachi E, Terdiman R, Peled Y. Alterations of the colonic flora and their effect on the hydrogen breath test. Gut. 1978;19:602\u2013605.","journal-title":"Gut"},{"key":"5830_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/1756283X11428502","volume":"5","author":"T Kelesidis","year":"2012","unstructured":"Kelesidis T. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Ther Adv Gastroenterol. 2012;5:111\u2013125. \nhttps:\/\/doi.org\/10.1177\/1756283X11428502","journal-title":"Ther Adv Gastroenterol"},{"key":"5830_CR31","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1001\/jama.1994.03510480037031","volume":"271","author":"LV McFarland","year":"1994","unstructured":"McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994;271:1913\u20131918. \nhttps:\/\/doi.org\/10.1001\/jama.1994.03510480037031\n\n.","journal-title":"JAMA"},{"key":"5830_CR32","first-page":"111","volume":"13","author":"EC Lauritano","year":"2009","unstructured":"Lauritano EC, Gabrielli M, Scarpellini E, et al. Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazol. Eur Rev Med Pharmacol Sci. 2009;13:111\u2013116.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5830_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00535-017-1371-9","volume":"53","author":"T Su","year":"2018","unstructured":"Su T, Lai S, Lee A, He X, Chen S. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth. J Gastroenterol.. 2018;53:27\u201336. \nhttps:\/\/doi.org\/10.1007\/s00535-017-1371-9\n\n.","journal-title":"J Gastroenterol."},{"key":"5830_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","volume":"11","author":"WK Lo","year":"2013","unstructured":"Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:483\u2013490. \nhttps:\/\/doi.org\/10.1016\/j.cgh.2012.12.011\n\n.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5830_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/rheumatology\/ken485","volume":"48","author":"A Forbes","year":"2008","unstructured":"Forbes A, Marie I. Gastrointestinal complications: the most frequent internal complications of systemic sclerosis. Rheumatology. 2008;48:36\u201339. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/ken485\n\n.","journal-title":"Rheumatology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05830-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05830-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05830-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T19:19:20Z","timestamp":1600715960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05830-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,23]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["5830"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05830-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,23]]},"assertion":[{"value":"30 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committees and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}}]}}